Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06593847 · ClinicalTrials.gov registry record · NA
Multisite Virtual Reality Intervention for Speech Anxiety
A NA study, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 1,542
- Enrollment target
NCT06593847 is a NA study that has completed, run by Boston University Charles River Campus. The registered enrollment target is 1,542 participants.
The verdict
NCT06593847, a NA study, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,542 participants
- Enrollment target
Study Summary
Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present multicenter study (conducted through the Exposure Therapy Consortium) is designed to evaluate whether trait versus state positive affectivity is a more effective predictor of exposure therapy outcomes. Further, the investigators will examine whether the predictive significance of trait positive affectivity can be accounted for by examination of baseline levels of self-efficacy, hope, and optimism.
Interventions
- BEHAVIORAL Single-session VR exposure intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,542 participants |
| Start Date | 2024-10-08 |
| Est. Completion | 2025-07-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06593847
The ClinicalTrials.gov registry entry for NCT06593847 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,542 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University Charles River Campus, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Single-session VR exposure intervention is the first listed.
NCT06593847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06593847 about?
NCT06593847 is a clinical study titled "Multisite Virtual Reality Intervention for Speech Anxiety". Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present multicenter study (conducted through the Exposure Therapy Consortium) is designed to evaluate whether trait versus state posi...
What is the current status of trial NCT06593847?
This trial is currently completed. It is a NA study. The enrollment target is 1,542 participants. The study started on 2024-10-08. Estimated completion is 2025-07-23.
What interventions are being tested in trial NCT06593847?
The interventions under investigation include: Single-session VR exposure intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06593847?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.